Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016809
Chunk: 110

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 110
---
 6-K, filed with the SEC on December 21, 2023).                                                                                                                                                                                                                            |
| 4.13    |     | Form of Series G Warrant (incorporated by reference to Exhibit 4.1 of the Company’s Report on Form 6-K, filed with the SEC on May 28, 2024).                                                                                                                                                                                                                                                  |

| 59 |

| 4.14   
 4.15   |     | Form of Warrant Agent Warrant (incorporated by reference to Exhibit 4.3 of the Company’s Report on Form 6-K, filed with the SEC on May 28, 2024).                                                                                                                                           
 Form of Series J Warrant (incorporated by reference to Exhibit 4.1 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                               |
|:-------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.16   |     | Form of July 2024 Placement Agent Warrant (incorporated by reference to Exhibit 4.3 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                              |
| 4.17   |     | Form of Pre-Funded Warrant  (incorporated by reference to Exhibit 4.4 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                            |
| 5.1*   |     | Opinion of Brown Rudnick LLP (incorporated by reference to Exhibit 5.1 of the Company’s Registration Statement on Form F-1, filed with the SEC on June 16, 2023).                                                                                                                           |
| 10.1

#  |     | Biodexa PLC Enterprise Management Incentive and Unapproved Share Option Scheme (incorporated by reference to Exhibit 4.1 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the SEC on April 19, 2024).                                           |
| 10.2

#  |     | Form of Option Agreement (included in Exhibit 10.1).                                                                                                                                                                                                                                        |
| 10.3

#  |     | Form of Appointment Letter between Midatech Pharma PLC and certain directors of Midatech Pharma PLC (incorporated by reference to Exhibit